Laurens Kruidenier, PhD

Takeda Cambridge Limited
Cambridge United Kingdom Papers:
F.13 Identification of potential therapeutic macrophage-related targets for inflammatory bowel disease (IBD)
OR.67 H3K27me3 Contributes to the Establishment of Anergic Phenotype of Intestinal Macrophages